Loading company…
Oral Biolife develops dental treatments for periodontal disease, including a regenerative dental gel.
Founded in 2022 and based in Bethlehem, US, Oral Biolife develops Ambrilux Dental Gel for periodontal disease. The gel is applied directly to periodontal pockets and is intended for human and veterinary use. In October 2025, the company raised an undisclosed amount of venture funding to support preclinical and clinical programs and manufacturing.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in